相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131I-Metaiodobenzylguanidine (MIBG)
Megan Trieu et al.
PEDIATRIC BLOOD & CANCER (2016)
Biomarkers for immunotherapy in genitourinary malignancies
Susan F. Slovin
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
Hiroshi Maeda
ADVANCED DRUG DELIVERY REVIEWS (2015)
Monoclonal antibodies in acute lymphoblastic leukemia
Elias Jabbour et al.
BLOOD (2015)
Targeted radionuclide therapies for pancreatic cancer
M. Shah et al.
CANCER GENE THERAPY (2015)
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
Steven G. DuBois et al.
CLINICAL CANCER RESEARCH (2015)
Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)
Margaret J. Zhou et al.
EUROPEAN JOURNAL OF CANCER (2015)
Radium-223 in the Treatment of Osteoblastic Metastases: A Critical Clinical Review
John L. Humm et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Radiotherapy and Immunogenic Cell Death
Encouse B. Golden et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
Daiki Kayano et al.
TheScientificWorldJOURNAL (2015)
Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
Daiki Kayano et al.
Scientific World Journal (2015)
A pretargeting system for tumor PET imaging and radioimmunotherapy
Francoise Kraeber-Bodere et al.
FRONTIERS IN PHARMACOLOGY (2015)
Multifunctional nanoparticles for use in theranostic applications
James T. Cole et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2015)
Patient-Specific Dosimetry Using Pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) Dynamic PET/CT Imaging Before [131I]mIBG Targeted Radionuclide Therapy for Neuroblastoma
Shih-ying Huang et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Building better monoclonal antibody-based therapeutics
George J. Weiner
NATURE REVIEWS CANCER (2015)
Radioimmunotherapy of human tumours
Steven M. Larson et al.
NATURE REVIEWS CANCER (2015)
A practical approach to diagnose soft tissue myeloid sarcoma preceding or coinciding with acute myeloid leukemia
Robert P. Seifert et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2014)
Peptides for Diagnosis and Treatment of Colorectal Cancer
S. Shapira et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Radioimmunotherapy with a- particle- emitting radionuclides
Christof Seidl
IMMUNOTHERAPY (2014)
Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with 223Ra-Dichloride
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Therapeutic radionuclides in nuclear medicine: current and future prospects
Chai-Hong Yeong et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2014)
Radioimmunoconjugates for the Treatment of Cancer
Francoise Kraeber-Bodere et al.
SEMINARS IN ONCOLOGY (2014)
Radiolabeled Apoptosis Imaging Agents for Early Detection of Response to Therapy
Kazuma Ogawa et al.
TheScientificWorldJOURNAL (2014)
Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
Lisa Bodei et al.
THORACIC SURGERY CLINICS (2014)
The Role of PAM4 in the Management of Pancreatic Cancer: Diagnosis, Radioimmunodetection, and Radioimmunotherapy
Suxia Han et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
CD5- and CD23-Positive Splenic Diffuse Large B-Cell Lymphoma with Very Low CD20 Expression
Rie Tabata et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2014)
Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
June-Key Chung et al.
ENDOCRINOLOGY AND METABOLISM (2014)
Role of consolidation with yttrium-90 ibritumomab tiuxetan in patients with advanced-stage follicular lymphoma
Antonio C. Sanchez Ruiz et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2014)
A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP-Rituximab versus CHOP+131Iodine-Tositumomab
Oliver W. Press et al.
CLINICAL CANCER RESEARCH (2013)
Phase II Study of Lutetium-177-Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer
Scott T. Tagawa et al.
CLINICAL CANCER RESEARCH (2013)
Advances in Anticancer Radiopharmaceuticals
M. R. Jackson et al.
CLINICAL ONCOLOGY (2013)
Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation: do we really need this?
M. Fujiki et al.
CLINICAL TRANSPLANTATION (2013)
Radioimmunotherapy for hematopoietic cell transplantation
Joseph G. Jurcic
IMMUNOTHERAPY (2013)
Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus 131Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016
Oliver W. Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow-Up of 7.3 Years From the International, Randomized, Phase III First-Line Indolent Trial
Franck Morschhauser et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
Maddalena Sansovini et al.
NEUROENDOCRINOLOGY (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Targeted Radionuclide Therapy - An Overview
Ashutosh Dash et al.
CURRENT RADIOPHARMACEUTICALS (2013)
Effective use of strontium-89 in osseous metastases
Isao Kuroda
ANNALS OF NUCLEAR MEDICINE (2012)
Fractionated Radioimmunotherapy With 90Y-Clivatuzumab Tetraxetan and Low-Dose Gemcitabine Is Active in Advanced Pancreatic Cancer
Allyson J. Ocean et al.
CANCER (2012)
Optimizing radioimmunoconjugate delivery in the treatment of solid tumor
Chen-Yu Huang et al.
CANCER TREATMENT REVIEWS (2012)
Targeted radioimmunotherapy: the role of 131I-chTNT-1/B mAb (Cotara®) for treatment of high-grade gliomas
Alia Hdeib et al.
FUTURE ONCOLOGY (2012)
Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
Paola A. Erba et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Tumor Dosimetry Using [124I]m-iodobenzylguanidine MicroPET/CT for [131I]m-iodobenzylguanidine Treatment of Neuroblastoma in a Murine Xenograft Model
Youngho Seo et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
Pretargeted Molecular Imaging and Radioimmunotherapy
David M. Goldenberg et al.
THERANOSTICS (2012)
The Role of Bone-Seeking Radionuclides in the Palliative Treatment of Patients With Painful Osteoblastic Skeletal Metastases
Michael Tomblyn
CANCER CONTROL (2012)
Rhenium-188: Availability from the W-188/(188) Re Generator and Status of Current Applications
M. R. A. Pillai et al.
CURRENT RADIOPHARMACEUTICALS (2012)
Yttrium-90 DOTATOC therapy in GEP-NET and other SST2 expressing tumors: a selected review
Lutfun Nisa et al.
ANNALS OF NUCLEAR MEDICINE (2011)
Treatment of Advanced Pancreatic Carcinoma with 90Y-Clivatuzumab Tetraxetan: A Phase I Single-Dose Escalation Trial
Seza A. Gulec et al.
CLINICAL CANCER RESEARCH (2011)
Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanoma
Barry J. Allen et al.
IMMUNOTHERAPY (2011)
Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma through baculovirus: a comparative study with Bac-CMV-hNIS
Rui Guo et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
Thyroid and Hepatic Function After High-Dose 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Neuroblastoma
Alekist Quach et al.
PEDIATRIC BLOOD & CANCER (2011)
Astatine-211: Production and Availability
Michael R. Zalutsky et al.
CURRENT RADIOPHARMACEUTICALS (2011)
NF-κB p65 Subunit Mediates Lipopolysaccharide-Induced Na+/I- Symporter Gene Expression by Involving Functional Interaction with the Paired Domain Transcription Factor Pax8
Juan Pablo Nicola et al.
MOLECULAR ENDOCRINOLOGY (2010)
Antioxidative and Radiation Modulating Properties of Guanosine-5'-Monophosphate
N. R. Asadullina et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2010)
Radioimmunotherapy of Lymphoma: Bexxar and Zevalin
Stanley J. Goldsmith
SEMINARS IN NUCLEAR MEDICINE (2010)
New Antibody Conjugates in Cancer Therapy
Serengulam V. Govindan et al.
THESCIENTIFICWORLDJOURNAL (2010)
Sodium Iodide Symporter and the Radioiodine Treatment of Thyroid Carcinoma
June-Key Chung et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case
Roberto Ronca et al.
IMMUNOBIOLOGY (2009)
Protection of mice against X-ray injuries by the post-irradiation administration of guanosine and inosine
Sergey V. Gudkov et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2009)
Phase III Trial of Consolidation Therapy With Yttrium-90-Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma
Franck Morschhauser et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Anti-cancer therapies targeting the tumor stroma
Valeska Hofmeister et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
The importance of sodium/iodide symporter (NIS) for thyroid cancer management
Denise P. Carvalho et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2007)
Interim analysis of oxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma
Chand Raja et al.
CANCER BIOLOGY & THERAPY (2007)
High-linear energy transfer irradiation targeted to skeletal metastases by the α-emitter 223Ra:: Adjuvant or alternative to conventional modalities?
Oyvind S. Bruland et al.
CLINICAL CANCER RESEARCH (2006)
The anti-CD25 monoclonal antibody 7G7/B6, armed with the α-emitter 211At, provides effective radioimmunotherapy for a murine model of leukemia
Meili Zhang et al.
CANCER RESEARCH (2006)
Guanosine and inosine display antioxidant activity, protect DNA in vitro from oxidative damage induced by reactive oxygen species, and serve as radioprotectors in mice
SV Gudkov et al.
RADIATION RESEARCH (2006)
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labletuzumab after salvage resection of colorectal metastases in the liver:: Five-year safety and efficacy results
T Liersch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Transcriptional regulation of human sodium/iodide symporter gene: A role for redox factor-1
C Puppin et al.
ENDOCRINOLOGY (2004)
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: Phase I/II clinical trial results
JP Leonard et al.
CLINICAL CANCER RESEARCH (2004)
HLA class II antibodies in the treatment of hematologic malignancies
M Dechant et al.
SEMINARS IN ONCOLOGY (2003)
Therapeutic radionuclides and nuclear data
SM Qaim
RADIOCHIMICA ACTA (2001)
The AAPM/RSNA physics tutorial for residents - Internal radiation dosimetry: Principles and applications
RE Toohey et al.
RADIOGRAPHICS (2000)
分享论文
